Diagnostic utility of serum prostate-specific antigen and circulating inflammatory markers for differentiating prostate cancer from benign prostatic hyperplasia
The XGBoost model integrating NLR, LMR, and NAR demonstrates superior diagnostic accuracy and clinical utility compared with PSA and PHI, potentially improving pre-biopsy risk stratification and reducing unnecessary invasive procedures.
Authors
- Dawei Luo
Institutions
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- American Journal of Cancer Research
- Published
- 2025-01-01
- DOI
- https://doi.org/10.62347/qtaw5624
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00